These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3487629)

  • 1. Plasma osteocalcin levels in patients with osteogenesis imperfecta.
    Castells S; Yasumura S; Fusi MA; Colbert C; Bachtell RS; Smith S
    J Pediatr; 1986 Jul; 109(1):88-91. PubMed ID: 3487629
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in plasma osteocalcin concentrations during treatment of rickets.
    Greig F; Casas J; Castells S
    J Pediatr; 1989 May; 114(5):820-3. PubMed ID: 2785593
    [No Abstract]   [Full Text] [Related]  

  • 3. Osteocalcin levels in osteogenesis imperfecta.
    Rico H
    J Pediatr; 1987 Oct; 111(4):634. PubMed ID: 3498810
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum calcitonin and bone mineral content in patients with osteogenesis imperfecta.
    Nielsen HE; Pedersen U; Hansen HH; Elbrønd O
    Acta Orthop Scand; 1979 Dec; 50(6 Pt 1):639-43. PubMed ID: 532592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral content in osteogenesis imperfecta tarda and in otosclerosis.
    Pedersen U; Nielsen HE; Jensen KJ; Elbrønd O; Hansen HH
    J Laryngol Otol; 1979 Jul; 93(7):697-702. PubMed ID: 469399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total body and regional analysis by dual-photon absorptiometry in osteogenesis imperfecta.
    Nuti R; Righi G; Turchetti V; Martini G; Lepore C
    Ann N Y Acad Sci; 1988; 543():180-5. PubMed ID: 3265046
    [No Abstract]   [Full Text] [Related]  

  • 7. Decrease of serum alkaline phosphatase after three cycles of pamidronate disodium in children with severe osteogenesis imperfecta.
    Cabral de Menezes Filho H; Rodrigues JM; Radonsky V; Della Manna T; Kuperman H; Steinmetz L; Dichtchekenian V; Damiani D; Setian N
    Horm Res; 2007; 68 Suppl 5():207-8. PubMed ID: 18174750
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum osteocalcin in the treatment of inherited rickets with 1,25-dihydroxyvitamin D3.
    Gundberg CM; Cole DE; Lian JB; Reade TM; Gallop PM
    J Clin Endocrinol Metab; 1983 May; 56(5):1063-7. PubMed ID: 6601111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical analysis of bone compacta in osteogenesis imperfecta.
    Brenner RE; Vetter U; Wörsdorfer O; Nerlich A; Teller WM; Müller PK
    Ann N Y Acad Sci; 1988; 543():106-8. PubMed ID: 3214048
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum levels of osteocalcin (bone Gla protein) in normal children and Down's syndrome.
    Galli M; Caniggia I
    Panminerva Med; 1987; 29(2):139-42. PubMed ID: 2957641
    [No Abstract]   [Full Text] [Related]  

  • 11. Mineral changes in a transgenic mouse model for osteogenesis imperfecta.
    Cassella JP; Pereira R; Prockop DJ; Ali SY
    Br J Biomed Sci; 1996 Jun; 53(2):108-15. PubMed ID: 8757687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D metabolism in osteogenesis imperfecta during calcitonin therapy.
    Nishi Y; Hyodo S; Yoshimitsu K; Sawano K; Yamaoka K; Seino Y; Usui T
    Pediatrics; 1984 Apr; 73(4):538-42. PubMed ID: 6546792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteogenesis imperfecta: changes in noncollagenous proteins in bone.
    Vetter U; Fisher LW; Mintz KP; Kopp JB; Tuross N; Termine JD; Robey PG
    J Bone Miner Res; 1991 May; 6(5):501-5. PubMed ID: 2068957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis.
    Antoniazzi F; Bertoldo F; Mottes M; Valli M; Sirpresi S; Zamboni G; Valentini R; Tató L
    J Pediatr; 1996 Sep; 129(3):432-9. PubMed ID: 8804334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Values of noninvasive techniques in predicting bone histology.
    Malluche HH; Arnala I; Faugere MC
    Ann Chir Gynaecol; 1988; 77(5-6):246-50. PubMed ID: 3267106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Osteogenesis imperfecta tarda].
    Janssen G
    Z Orthop Ihre Grenzgeb; 1973 Aug; 111(4):592-3. PubMed ID: 4131007
    [No Abstract]   [Full Text] [Related]  

  • 17. Normal bone turnover in isolated hyperphosphatasemia.
    Kruse K
    J Pediatr; 1985 Jun; 106(6):946-8. PubMed ID: 3873534
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum 24,25-dihydroxyvitamin D concentrations in osteogenesis imperfecta: relationship to bone parameters.
    Edouard T; Husseini A; Glorieux FH; Rauch F
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1243-9. PubMed ID: 22319032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Osteocalcin, a marker in diseases with elevated bone metabolism].
    Stracke H; Schatz C; Pralle H; Ullmann J; Schatz H
    Dtsch Med Wochenschr; 1985 Sep; 110(38):1442-6. PubMed ID: 3875469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen.
    Marini JC; Hopkins E; Glorieux FH; Chrousos GP; Reynolds JC; Gundberg CM; Reing CM
    J Bone Miner Res; 2003 Feb; 18(2):237-43. PubMed ID: 12568401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.